The Clorox Company (NYSE:CLX) Shares Sold by Principal Financial Group Inc.

Principal Financial Group Inc. trimmed its position in shares of The Clorox Company (NYSE:CLXGet Rating) by 1.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 172,700 shares of the company’s stock after selling 2,467 shares during the period. Principal Financial Group Inc. owned 0.14% of Clorox worth $30,111,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Martin Capital Partners LLC boosted its stake in Clorox by 1.9% during the 4th quarter. Martin Capital Partners LLC now owns 3,022 shares of the company’s stock valued at $527,000 after purchasing an additional 57 shares during the period. Strategy Asset Managers LLC lifted its stake in shares of Clorox by 3.6% in the 3rd quarter. Strategy Asset Managers LLC now owns 1,670 shares of the company’s stock worth $277,000 after acquiring an additional 58 shares during the period. Corient Capital Partners LLC lifted its stake in shares of Clorox by 4.4% in the 3rd quarter. Corient Capital Partners LLC now owns 1,585 shares of the company’s stock worth $262,000 after acquiring an additional 67 shares during the period. OmniStar Financial Group Inc. lifted its stake in shares of Clorox by 4.4% in the 3rd quarter. OmniStar Financial Group Inc. now owns 1,822 shares of the company’s stock worth $301,000 after acquiring an additional 77 shares during the period. Finally, 55I LLC lifted its stake in shares of Clorox by 5.9% in the 4th quarter. 55I LLC now owns 1,425 shares of the company’s stock worth $249,000 after acquiring an additional 79 shares during the period. 77.28% of the stock is owned by hedge funds and other institutional investors.

A number of analysts have recently weighed in on CLX shares. UBS Group reduced their price target on shares of Clorox from $163.00 to $148.00 and set a “sell” rating for the company in a research note on Friday, February 4th. Atlantic Securities lowered shares of Clorox from a “neutral” rating to an “underweight” rating and set a $118.00 price target for the company. in a research note on Friday, February 4th. Barclays reduced their price target on shares of Clorox from $132.00 to $117.00 and set an “underweight” rating for the company in a research note on Friday, April 1st. StockNews.com assumed coverage on shares of Clorox in a report on Thursday, March 31st. They issued a “hold” rating on the stock. Finally, Wells Fargo & Company boosted their target price on shares of Clorox from $120.00 to $130.00 in a report on Tuesday, May 3rd. Ten investment analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell” and an average target price of $145.67.

CLX stock opened at $158.28 on Friday. The Clorox Company has a 52-week low of $127.02 and a 52-week high of $191.75. The company’s 50 day simple moving average is $143.21 and its 200-day simple moving average is $157.32. The company has a debt-to-equity ratio of 3.28, a current ratio of 0.71 and a quick ratio of 0.40. The firm has a market capitalization of $19.48 billion, a P/E ratio of 42.89, a P/E/G ratio of 5.32 and a beta of 0.18.

Clorox (NYSE:CLXGet Rating) last released its quarterly earnings results on Monday, May 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.34. Clorox had a net margin of 6.44% and a return on equity of 92.98%. During the same quarter last year, the company earned $1.62 EPS. Sell-side analysts predict that The Clorox Company will post 4.16 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 13th. Shareholders of record on Wednesday, April 27th were paid a $1.16 dividend. The ex-dividend date was Tuesday, April 26th. This represents a $4.64 annualized dividend and a yield of 2.93%. Clorox’s dividend payout ratio is presently 125.75%.

In other Clorox news, COO Eric H. Reynolds sold 585 shares of the company’s stock in a transaction that occurred on Monday, May 9th. The shares were sold at an average price of $154.83, for a total value of $90,575.55. Following the transaction, the chief operating officer now owns 17,289 shares in the company, valued at approximately $2,676,855.87. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.58% of the stock is currently owned by corporate insiders.

Clorox Profile (Get Rating)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXGet Rating).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.